 | • レポートコード：QYR2104Z1178 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、セリアック病のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（膨満、下痢、食欲不振、その他）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・セリアック病の市場動向 ・企業の競争状況、市場シェア ・セリアック病の種類別市場規模（膨満、下痢、食欲不振、その他） ・セリアック病の用途別市場規模（病院、クリニック） ・セリアック病の北米市場規模2016-2027（アメリカ、カナダ） ・セリアック病のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・セリアック病のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・セリアック病の中南米市場規模2016-2027（メキシコ、ブラジル） ・セリアック病の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Merck、Johnson & Johnson、BiolineRx、Pfizer、Innovate Biopharmaceuticals、ImmusanT、Novartis、Bristol-Myers Squibb、Immunomedics） ・結論 |
Market Analysis and Insights: Global Celiac Disease Market
The global Celiac Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Celiac Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Celiac Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Celiac Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Celiac Disease market.
Global Celiac Disease Scope and Market Size
Celiac Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Celiac Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Distension
Diarrhea
Anorexia
Others
Segment by Application
Hospital
Clinic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Celiac Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Distension
1.2.3 Diarrhea
1.2.4 Anorexia
1.2.5 Others
1.3 Market by Application
1.3.1 Global Celiac Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Celiac Disease Market Perspective (2016-2027)
2.2 Celiac Disease Growth Trends by Regions
2.2.1 Celiac Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Celiac Disease Historic Market Share by Regions (2016-2021)
2.2.3 Celiac Disease Forecasted Market Size by Regions (2022-2027)
2.3 Celiac Disease Industry Dynamic
2.3.1 Celiac Disease Market Trends
2.3.2 Celiac Disease Market Drivers
2.3.3 Celiac Disease Market Challenges
2.3.4 Celiac Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Celiac Disease Players by Revenue
3.1.1 Global Top Celiac Disease Players by Revenue (2016-2021)
3.1.2 Global Celiac Disease Revenue Market Share by Players (2016-2021)
3.2 Global Celiac Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Celiac Disease Revenue
3.4 Global Celiac Disease Market Concentration Ratio
3.4.1 Global Celiac Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Celiac Disease Revenue in 2020
3.5 Celiac Disease Key Players Head office and Area Served
3.6 Key Players Celiac Disease Product Solution and Service
3.7 Date of Enter into Celiac Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Celiac Disease Breakdown Data by Type
4.1 Global Celiac Disease Historic Market Size by Type (2016-2021)
4.2 Global Celiac Disease Forecasted Market Size by Type (2022-2027)
5 Celiac Disease Breakdown Data by Application
5.1 Global Celiac Disease Historic Market Size by Application (2016-2021)
5.2 Global Celiac Disease Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Celiac Disease Market Size (2016-2027)
6.2 North America Celiac Disease Market Size by Type
6.2.1 North America Celiac Disease Market Size by Type (2016-2021)
6.2.2 North America Celiac Disease Market Size by Type (2022-2027)
6.2.3 North America Celiac Disease Market Size by Type (2016-2027)
6.3 North America Celiac Disease Market Size by Application
6.3.1 North America Celiac Disease Market Size by Application (2016-2021)
6.3.2 North America Celiac Disease Market Size by Application (2022-2027)
6.3.3 North America Celiac Disease Market Size by Application (2016-2027)
6.4 North America Celiac Disease Market Size by Country
6.4.1 North America Celiac Disease Market Size by Country (2016-2021)
6.4.2 North America Celiac Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Celiac Disease Market Size (2016-2027)
7.2 Europe Celiac Disease Market Size by Type
7.2.1 Europe Celiac Disease Market Size by Type (2016-2021)
7.2.2 Europe Celiac Disease Market Size by Type (2022-2027)
7.2.3 Europe Celiac Disease Market Size by Type (2016-2027)
7.3 Europe Celiac Disease Market Size by Application
7.3.1 Europe Celiac Disease Market Size by Application (2016-2021)
7.3.2 Europe Celiac Disease Market Size by Application (2022-2027)
7.3.3 Europe Celiac Disease Market Size by Application (2016-2027)
7.4 Europe Celiac Disease Market Size by Country
7.4.1 Europe Celiac Disease Market Size by Country (2016-2021)
7.4.2 Europe Celiac Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Celiac Disease Market Size (2016-2027)
8.2 Asia-Pacific Celiac Disease Market Size by Type
8.2.1 Asia-Pacific Celiac Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Celiac Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Celiac Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Celiac Disease Market Size by Application
8.3.1 Asia-Pacific Celiac Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Celiac Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Celiac Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Celiac Disease Market Size by Region
8.4.1 Asia-Pacific Celiac Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Celiac Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Celiac Disease Market Size (2016-2027)
9.2 Latin America Celiac Disease Market Size by Type
9.2.1 Latin America Celiac Disease Market Size by Type (2016-2021)
9.2.2 Latin America Celiac Disease Market Size by Type (2022-2027)
9.2.3 Latin America Celiac Disease Market Size by Type (2016-2027)
9.3 Latin America Celiac Disease Market Size by Application
9.3.1 Latin America Celiac Disease Market Size by Application (2016-2021)
9.3.2 Latin America Celiac Disease Market Size by Application (2022-2027)
9.3.3 Latin America Celiac Disease Market Size by Application (2016-2027)
9.4 Latin America Celiac Disease Market Size by Country
9.4.1 Latin America Celiac Disease Market Size by Country (2016-2021)
9.4.2 Latin America Celiac Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Celiac Disease Market Size (2016-2027)
10.2 Middle East & Africa Celiac Disease Market Size by Type
10.2.1 Middle East & Africa Celiac Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Celiac Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Celiac Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Celiac Disease Market Size by Application
10.3.1 Middle East & Africa Celiac Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Celiac Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Celiac Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Celiac Disease Market Size by Country
10.4.1 Middle East & Africa Celiac Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Celiac Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Celiac Disease Introduction
11.1.4 Roche Revenue in Celiac Disease Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Celiac Disease Introduction
11.2.4 Merck Revenue in Celiac Disease Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Celiac Disease Introduction
11.3.4 Johnson & Johnson Revenue in Celiac Disease Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 BiolineRx
11.4.1 BiolineRx Company Details
11.4.2 BiolineRx Business Overview
11.4.3 BiolineRx Celiac Disease Introduction
11.4.4 BiolineRx Revenue in Celiac Disease Business (2016-2021)
11.4.5 BiolineRx Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Celiac Disease Introduction
11.5.4 Pfizer Revenue in Celiac Disease Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Innovate Biopharmaceuticals
11.6.1 Innovate Biopharmaceuticals Company Details
11.6.2 Innovate Biopharmaceuticals Business Overview
11.6.3 Innovate Biopharmaceuticals Celiac Disease Introduction
11.6.4 Innovate Biopharmaceuticals Revenue in Celiac Disease Business (2016-2021)
11.6.5 Innovate Biopharmaceuticals Recent Development
11.7 ImmusanT
11.7.1 ImmusanT Company Details
11.7.2 ImmusanT Business Overview
11.7.3 ImmusanT Celiac Disease Introduction
11.7.4 ImmusanT Revenue in Celiac Disease Business (2016-2021)
11.7.5 ImmusanT Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Celiac Disease Introduction
11.8.4 Novartis Revenue in Celiac Disease Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Celiac Disease Introduction
11.9.4 Bristol-Myers Squibb Revenue in Celiac Disease Business (2016-2021)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Immunomedics
11.10.1 Immunomedics Company Details
11.10.2 Immunomedics Business Overview
11.10.3 Immunomedics Celiac Disease Introduction
11.10.4 Immunomedics Revenue in Celiac Disease Business (2016-2021)
11.10.5 Immunomedics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Celiac Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Distension
Table 3. Key Players of Diarrhea
Table 4. Key Players of Anorexia
Table 5. Key Players of Others
Table 6. Global Celiac Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Celiac Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Celiac Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Celiac Disease Market Share by Regions (2016-2021)
Table 10. Global Celiac Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Celiac Disease Market Share by Regions (2022-2027)
Table 12. Celiac Disease Market Trends
Table 13. Celiac Disease Market Drivers
Table 14. Celiac Disease Market Challenges
Table 15. Celiac Disease Market Restraints
Table 16. Global Celiac Disease Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Celiac Disease Market Share by Players (2016-2021)
Table 18. Global Top Celiac Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Celiac Disease as of 2020)
Table 19. Ranking of Global Top Celiac Disease Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Celiac Disease Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Celiac Disease Product Solution and Service
Table 23. Date of Enter into Celiac Disease Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Celiac Disease Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Celiac Disease Revenue Market Share by Type (2016-2021)
Table 27. Global Celiac Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Celiac Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Celiac Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Celiac Disease Revenue Market Share by Application (2016-2021)
Table 31. Global Celiac Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Celiac Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Celiac Disease Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Celiac Disease Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Celiac Disease Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Celiac Disease Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Celiac Disease Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Celiac Disease Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Celiac Disease Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Celiac Disease Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Celiac Disease Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Celiac Disease Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Celiac Disease Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Celiac Disease Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Celiac Disease Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Celiac Disease Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Celiac Disease Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Celiac Disease Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Celiac Disease Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Celiac Disease Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Celiac Disease Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Celiac Disease Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Celiac Disease Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Celiac Disease Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Celiac Disease Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Celiac Disease Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Celiac Disease Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Celiac Disease Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Celiac Disease Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Celiac Disease Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Celiac Disease Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Celiac Disease Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Celiac Disease Product
Table 66. Roche Revenue in Celiac Disease Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Merck Company Details
Table 69. Merck Business Overview
Table 70. Merck Celiac Disease Product
Table 71. Merck Revenue in Celiac Disease Business (2016-2021) & (US$ Million)
Table 72. Merck Recent Development
Table 73. Johnson & Johnson Company Details
Table 74. Johnson & Johnson Business Overview
Table 75. Johnson & Johnson Celiac Disease Product
Table 76. Johnson & Johnson Revenue in Celiac Disease Business (2016-2021) & (US$ Million)
Table 77. Johnson & Johnson Recent Development
Table 78. BiolineRx Company Details
Table 79. BiolineRx Business Overview
Table 80. BiolineRx Celiac Disease Product
Table 81. BiolineRx Revenue in Celiac Disease Business (2016-2021) & (US$ Million)
Table 82. BiolineRx Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Celiac Disease Product
Table 86. Pfizer Revenue in Celiac Disease Business (2016-2021) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Innovate Biopharmaceuticals Company Details
Table 89. Innovate Biopharmaceuticals Business Overview
Table 90. Innovate Biopharmaceuticals Celiac Disease Product
Table 91. Innovate Biopharmaceuticals Revenue in Celiac Disease Business (2016-2021) & (US$ Million)
Table 92. Innovate Biopharmaceuticals Recent Development
Table 93. ImmusanT Company Details
Table 94. ImmusanT Business Overview
Table 95. ImmusanT Celiac Disease Product
Table 96. ImmusanT Revenue in Celiac Disease Business (2016-2021) & (US$ Million)
Table 97. ImmusanT Recent Development
Table 98. Novartis Company Details
Table 99. Novartis Business Overview
Table 100. Novartis Revenue in Celiac Disease Business (2016-2021) & (US$ Million)
Table 101. Novartis Recent Development
Table 102. Bristol-Myers Squibb Company Details
Table 103. Bristol-Myers Squibb Business Overview
Table 104. Bristol-Myers Squibb Celiac Disease Product
Table 105. Bristol-Myers Squibb Revenue in Celiac Disease Business (2016-2021) & (US$ Million)
Table 106. Bristol-Myers Squibb Recent Development
Table 107. Immunomedics Company Details
Table 108. Immunomedics Business Overview
Table 109. Immunomedics Celiac Disease Product
Table 110. Immunomedics Revenue in Celiac Disease Business (2016-2021) & (US$ Million)
Table 111. Immunomedics Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Celiac Disease Market Share by Type: 2020 VS 2027
Figure 2. Distension Features
Figure 3. Diarrhea Features
Figure 4. Anorexia Features
Figure 5. Others Features
Figure 6. Global Celiac Disease Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Celiac Disease Report Years Considered
Figure 10. Global Celiac Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Celiac Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Celiac Disease Market Share by Regions: 2020 VS 2027
Figure 13. Global Celiac Disease Market Share by Regions (2022-2027)
Figure 14. Global Celiac Disease Market Share by Players in 2020
Figure 15. Global Top Celiac Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Celiac Disease as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Celiac Disease Revenue in 2020
Figure 17. Global Celiac Disease Revenue Market Share by Type (2016-2021)
Figure 18. Global Celiac Disease Revenue Market Share by Type (2022-2027)
Figure 19. North America Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Celiac Disease Market Share by Type (2016-2027)
Figure 21. North America Celiac Disease Market Share by Application (2016-2027)
Figure 22. North America Celiac Disease Market Share by Country (2016-2027)
Figure 23. United States Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Celiac Disease Market Share by Type (2016-2027)
Figure 27. Europe Celiac Disease Market Share by Application (2016-2027)
Figure 28. Europe Celiac Disease Market Share by Country (2016-2027)
Figure 29. Germany Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Celiac Disease Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Celiac Disease Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Celiac Disease Market Share by Region (2016-2027)
Figure 39. China Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Celiac Disease Market Share by Type (2016-2027)
Figure 47. Latin America Celiac Disease Market Share by Application (2016-2027)
Figure 48. Latin America Celiac Disease Market Share by Country (2016-2027)
Figure 49. Mexico Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Celiac Disease Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Celiac Disease Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Celiac Disease Market Share by Country (2016-2027)
Figure 55. Turkey Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Celiac Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Roche Revenue Growth Rate in Celiac Disease Business (2016-2021)
Figure 59. Merck Revenue Growth Rate in Celiac Disease Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Celiac Disease Business (2016-2021)
Figure 61. BiolineRx Revenue Growth Rate in Celiac Disease Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Celiac Disease Business (2016-2021)
Figure 63. Innovate Biopharmaceuticals Revenue Growth Rate in Celiac Disease Business (2016-2021)
Figure 64. ImmusanT Revenue Growth Rate in Celiac Disease Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Celiac Disease Business (2016-2021)
Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Celiac Disease Business (2016-2021)
Figure 67. Immunomedics Revenue Growth Rate in Celiac Disease Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界のセリアック病治療薬市場規模・現状・予測（2021年-2027年） Celiac disease is a genetic, auto-immune disorder that affects the small intestine upon consumption of gluten. Celiac diseases may contribute to various diseases and disorders such as low bone density, neurological disorders, infertility, and certain cancers. Market Analysis and Insights: Global Cel…- 世界のサンドホフ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sandhoff Disease Therapeutics Market The global Sandhoff Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 世界のクラッベ病治療市場規模・現状・予測（2021年-2027年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- 世界の院内感染症検査市場規模・現状・予測（2021年-2027年） Hosptial infection is categorized based on infection types into the following segments: blood stream infection (BSI) testing, urinary tract infection (UTI) testing, methicilin-resistant staphylococcus aureus (MRSA) testing, pneumonia testing, surgical site infection (SSI) testing & others infections…
- 世界の非アルコール性脂肪肝疾患治療薬市場規模・現状・予測（2021年-2027年） Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver …